Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine

Infection and Immunity

Volumn 76, Issue 12, 2008, Pages 5543-5552

  Mesquita, Rafael D ^a,d   Carneiro, Alan Brito ^a   Bafica, André ^b   Gazos Lopes, Felipe ^a   Takiya, Christina M ^a   Souto Padron, Thaís ^a   Vieira, Danielle P ^a   Ferreira Pereira, Antônio ^a   Almeida, Igor C ^c   Figueiredo, Rodrigo T ^a   Porto, Bárbara N ^a   Bozza, Marcelo T ^a   Graça Souza, Aurélio V ^a   Lopes, Angela H C S ^a   Atella, Geórgia C ^a   Silva Neto, Mário A C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF TEXAS AT EL PASO   (United States)

^d CEFET Química de Nilópolis   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CHEMOTAXIS; CONTROLLED STUDY; DISEASE TRANSMISSION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SALIVA; TRIATOMINAE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; CHEMOTAXIS, LEUKOCYTE; CHROMATOGRAPHY, THIN LAYER; CYTOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSECT VECTORS; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MALE; MICE; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PARASITEMIA; RHODNIUS; SALIVA; TRYPANOSOMA CRUZI;

EID: 57349124786     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00683-08     Document Type: Article

References (68)

1. Agusti, R., A. S. Couto, M. J. M. Alves, W. Colli, and R. M. Lederkremer. 2000. Lipids shed into the culture medium by trypomastigotes of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 95:97-102.
2. Aliberti, J. C., M. A. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Q. Vieira, and J. S. Silva. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1961-1967.
3. Almeida, I. C., M. M. Camargo, D. O. Procopio, L. S. Silva, A. Mehlert, L. R. Travassos, R. T. Gazzinelli, and M. A. Ferguson. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19:1476-1485.
4. Amura, C. R., T. Kamei, N. Ito, M. J. Soares, and D. C. Morrison. 1998. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J. Immunol. 161:2552-2560.
5. Andrade, L. O., and N. W. Andrews. 2005. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 3:819-823.
6. Aprahamian, T., I. Rifkin, R. Bonegio, B. Hungel, J. M. Freyssinet, K. Sato, J. J. Castellot, Jr., and K. Walsh. 2004. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199:1121-1131.
7. 2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med. 204:929-940.
8. Atella, G. C., M. A. Arruda, K. C. Gondim, and H. Masuda. 2000. Fatty acid incorporation by Rhodnius prolixus midgut. Arch. Insect Biochem. Physiol. 43:99-107.
9. Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202:1715-1724.
10. Bafica, A., H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher. 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177:3515-3519.
11. Bisaggio, D. F., C. E. Peres-Sampaio, J. R. Meyer-Fernandes, and T. Souto-Padron. 2003. Ecto-ATPase activity on the surface of Trypanosoma cruzi and its possible role in the parasite-host cell interaction. Parasitol. Res. 91:273-282.
12. Burleigh, B. A., and A. M. Woolsey. 2002. Cell signalling and Trypanosoma cruzi invasion. Cell Microbiol. 4:701-711.
13. Camargo, E. P. 1964. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev. Inst. Méd. Trop. São Paulo 12:93-100.
14. Campos, M. A., I. C. Almeida, O. Takeuchi, S. Akira, E. P. Valente, D. O. Procopio, L. R. Travassos, J. A. Smith, D. T. Golenbock, and R. T. Gazzinelli. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidyl-inositol anchors from a protozoan parasite. J. Immunol. 167:416-423.
15. Campos, M. A., M. Closel, E. P. Valente, J. E. Cardoso, S. Akira, J. I. Alvarez-Leite, C. Ropert, and R. T. Gazzinelli. 2004. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 172:1711-1718.
16. Chagas, C. 1909. Neue Trypanosomen: Vorläufige mitteilung. Archiv fur Schiffs-und Tropen-Hygiene 13:120-122.
17. Chagas, C. 1909. Nouvelle espèce de trypanosomiase humaine. Bull. Soc. Pathol. Exotique 2:304-307.
18. Chagas, C. 1909. New human trypanosomiasis. Morphology and life cycle of Schyzotrypanum cruzi, the cause of a new human disease. Mem. Inst. Oswaldo Cruz 1:159-218.
19. Chai, Y. C., P. H. Howe, P. E. DiCorleto, and G. M. Chisolm. 1996. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J. Biol. Chem. 271:17791-17797.
20. Chen, L., T. Watanabe, H. Watanabe, and F. Sendo. 2001. Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur. J. Immunol. 31:265-275.
21. Contreras, V. T., J. M. Salles, N. Thomas, C. M. Morel, and S. Goldenberg. 1985. In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol. Biochem. Parasitol. 16:315-327.
22. Dias, J. C. P., A. C. Silveira, and C. J. Schofield. 2002. The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz 97:603-612.
23. Freire-de-Lima, C. G., D. O. Nascimento, M. B. Soares, P. T. Bozza, H. C. Castro-Faria-Neto, F. G. de Mello, G. A. Dos Reis, and M. F. Lopes. 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403:199-203.
24. Golodne, D. M., R. Q. Monteiro, A. V. Graça-Souza, M. A. C. Silva-Neto, and G. C. Atella. 2003. Lysophosphatidylcholine acts as an anti-hemostatic molecule in the saliva of the blood-sucking bug Rhodnius prolixus. J. Biol. Chem. 278:27766-27771.
25. Gomes, M. T., R. Q. Monteiro, L. A. Grillo, F. Leite-Lopes, H. Stroeder, A. Ferreira-Pereira, C. S. Alviano, E. Barreto-Bergter, H. C. Neto, E. S. N. L. Cunha, I. C. Almeida, R. M. Soares, and A. H. Lopes. 2006. Platelet-activating factor-like activity isolated from Trypanosoma cruzi. Int. J. Parasitol. 36:165-173.
26. Hall, L. R., and R. G. Titus. 1995. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J. Immunol. 155:3501-3506.
27. Huang, A., C. Li, R. L. Kao, and W. L. Stone. 1999. Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages. Free Radic. Biol. Med. 26:526-537.
28. Itabe, H. 1998. Oxidized phospholipids as a new landmark in atherosclerosis. Prog. Lipid Res. 37:181-207.
29. Kalvachova, P., V. Hribalova, P. Kodym, and P. Volf. 1999. Modulation of murine lymphocyte responsiveness by the saliva of Rhodnius prolixus (Hemiptera: Reduviidae). J. Med. Entomol. 36:341-344.
30. Kamhawi, S. 2000. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect. 2:1765-1773.
31. Koga, R., S. Hamano, H. Kuwata, K. Atarashi, M. Ogawa, H. Hisaeda, M. Yamamoto, S. Akira, K. Himeno, M. Matsumoto, and K. Takeda. 2006. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J. Immunol. 177:7059-7066.
32. Kollien, A. H., and G. A. Schaub. 2000. The development of Trypanosoma cruzi in triatominae. Parasitol. Today 16:381-387.
33. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162.
34. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, Y. Xu, I. B. Autenrieth, K. Schulze-Osthoff, C. Belka, G. Stuhler, and S. Wesselborg. 2003. Apoptotic cells induce migration of phagocytes via caspase-3 mediated release of a lipid attraction signal. Cell 113:717-730.
35. 2+ influx induced by dimethylphytosphingosine and lysophosphatidylcholine in U937 monocytes. Biochem. Biophys. Res. Commun. 348:1116-1122.
36. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randal. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
37. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
38. Mbow, M. L., J. A. Bleyenberg, L. R. Hall, and R. G. Titus. 1998. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. J. Immunol. 161:5571-5577.
39. McIntyre, T. M., G. A. Zimmerman, and S. M. Prescott. 1999. Biologically active oxidized phospholipids. J. Biol. Chem. 274:25189- 25192.
40. McMurray, H. F., S. Parthasarathy, and D. Steinberg. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Investig. 92:1004-1008.
41. Mesquita, R. D., F. B. M. Oliveira, D. Shugar, M. R. Fantappié, and M. A. Silva-Neto. 2005. Nitrophorin synthesis is modulated by protein kinase CK2. Biochem. Biophys. Res. Commun. 335:690-699.
42. Meyer zu Heringdorf, D., and K. H. Jakobs. 2007. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 1768:923-940.
43. Montgomery, R. R., D. Lusitani, A. De Boisfleury Chevance, and S. E. Malawista. 2004. Tick saliva reduces adherence and area of human neutrophils. Infect. Immun. 72:2989-2994.
44. Norsworthy, N. B., J. Sun, D. Elnaiem, G. Lanzaro, and L. Soong. 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72:1240-1247.
45. 2+ signaling via the platelet-activating factor receptor in macrophages. Am. J. Physiol. 272:H17-H24.
46. Oliveira, A. C., J. R. Peixoto, L. B. Arruda, M. A. Campos, R. T. Gazzinelli, D. T. Golenbock, S. Akira, J. O. Previato, L. Mendonça- Previato, A. Nobrega, and M. Bellio. 2004. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 173:5688-5696.
47. Porto, B. N., L. S. Alves, P. L. Fernandez, T. P. P. Dutra, R. T. Figueiredo, A. Graca-Souza, and M. T. Bozza. 2007. Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. J. Biol. Chem. 282:24430-24436.
48. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85:2805-2809.
49. Qureshi, A. A., A. Asahina, M. Ohnuma, M. Tajima, R. D. Granstein, and E. A. Lerner. 1996. Immunomodulatory properties of maxadilan, the vasodilator peptide from sand fly salivary gland extracts. Am. J. Trop. Med. Hyg. 54:665-671.
50. Radu, C. G., L. V. Yang, M. Riedinger, M. Au, and O. N. Witte. 2004. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc. Natl. Acad. Sci. USA 101:245-250.
51. Ribeiro, J. M., J. Andersen, M. A. Silva-Neto, V. M. Pham, M. K. Garfield, and J. G. Valenzuela. 2004. Exploring the sialome of the blood-sucking bug Rhodnius prolixus. Insect Biochem. Mol. Biol. 34:61-79.
52. 2 neurotoxins and lysophospholipid-fatty acid mixtures. Science 310:1678-1680.
53. Rogers, M. E., and P. A. Bates. 2007. Leishmania manipulation of sand fly feeding behavior results in enhanced transmission. PLoS Pathog. 3:e91.
54. Rosa, M. S., R. B. Vieira, A. F. Pereira, P. M. Dutra, and A. H. Lopes. 2001. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. Curr. Microbiol. 43:33-37.
55. Ryborg, A. K., B. Deleuran, H. Sogaard, and K. Kragballe. 2000. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Derm. Venereol. 80:242-246.
56. Saiga, A., Y. Morioka, T. Ono, K. Nakano, Y. Ishimoto, H. Arita, and K. Hanasaki. 2001. Group X secretory phospholipase A(2) induces potent productions of various lipid mediators in mouse peritoneal macrophages. Biochim. Biophys. Acta 1530:67-76.
57. Sá-Nunes, A., A. Bafica, D. A. Lucas, T. P. Conrads, T. D. Veenstra, J. F. Andersen, T. N. Mather, J. M. Ribeiro, and I. M. Francischetti. 2007. Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 179:1497-1505.
58. Schneider, B. S., L. Soong, N. S. Zeidener, and S. Higgs. 2004. Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. Viral Immunol. 17:565-573.
59. Schuster, J. P., and G. A. Schaub. 2000. Trypanosoma cruzi: skin-penetration kinetics of vector-derived metacyclic trypomastigotes. Int. J. Parasitol. 30:1475-1479.
60. Scott, G. A., M. Arioka, and S. E. Jacobs. 2007. Lysophosphatidylcholine mediates melanocyte dendricity through PKCzeta activation. J. Investig. Dermatol. 127:668-675.
61. Takahara, N., A. Kashiwagi, H. Maegawa, and Y. Shigeta. 1996. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45:559-564.
62. Tarleton, R. L. 2007. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19:430-434.
63. Titus, R. G., and J. M. Ribeiro. 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239:1306-1308.
64. Urbina, J. A., and R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends in Parasitol. 19:495-501.
65. Vespa, G. N., F. Q. Cunha, and J. S. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
66. Werling, D., J. C. Hope, C. J. Howard, and T. W. Jungi. 2004. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology. 111:41-52.
67. Xu, Y., Y. J. Xiao, K. Zhu, L. M. Baudhuin, J. Lu, G. Hong, K. S. Kim, K. L. Cristina, L. Song, S. Williams, F., P. Elson, M. Markman, and J. Belinson. 2003. Unfolding the pathophysiological role of bioactive lysophospholipids. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3:23-32.
68. Yan, J. J., J. S. Jung, J. E. Lee, J. Lee, S. O. Huh, H. S. Kim, K. C. Jung, J. Y. Cho, J. S. Nam, H. W. Suh, Y. H. Kim, and D. K. Song. 2004. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10:161-167.